autoimmune diseases
Showing NaN - NaN of 12
Stroke, Subarachnoid Hemorrhage, Traumatic Brain Injury Trial in London (Music Therapy, Control Therapy)
Not yet recruiting
- Stroke
- +8 more
- Music Therapy
- Control Therapy
-
London, United KingdomUniversity College Hospitals NHS Foundation Trust
Mar 8, 2023
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in London (Dexcom G6, Self monitoring of blood glucose)
Recruiting
- Diabetes Mellitus
- +5 more
- Dexcom G6
- Self monitoring of blood glucose
-
London, United KingdomImperial College Clinical Research Facility
Jun 23, 2022
Lateral Flow Immunoassays for Detection of SARS-CoV-2 Antibodies
Recruiting
- Solid Organ Transplant Recipients
- +2 more
- self-administered lateral flow assays
-
Bristol, United Kingdom
- +3 more
May 25, 2022
Prospective Study of White Blood Cells
Recruiting
- Autoimmune Diseases
- +2 more
- White blood cell and blood collection
-
London, United KingdomQuell Investigator Site 01
Apr 6, 2021
Neurological Disorder, Autoimmune Diseases Trial in Canada, United States (Mycophenolate Mofetil, Azathioprine)
Completed
- Neurological Disorder
- Autoimmune Diseases
- Mycophenolate Mofetil
- Azathioprine
-
Palo Alto, California
- +18 more
Feb 2, 2021
Autoimmune Diseases, Relapsing Multiple Sclerosis Trial in London (Fecal microbiota)
Terminated
- Autoimmune Diseases
- Relapsing Multiple Sclerosis
- Fecal microbiota
-
London, Ontario, CanadaLondon Health Sciences Centre, University Hospital
Nov 12, 2019
Autoimmune Diseases Trial in Cambridge, London (18F-FDG PET/CT Imaging, 11C-MET PET/CT Imaging, MRI Imaging with intravenous
Completed
- Autoimmune Diseases
- 18F-FDG PET/CT Imaging
- +3 more
-
Cambridge, United Kingdom
- +3 more
Oct 23, 2019
Autoimmune Diseases Trial in London (Azithromycin - 250 mg, Azithromycin - 1000 mg, Azithromycin - 250 mg every other day for 3
Completed
- Autoimmune Diseases
- Azithromycin - 250 mg
- +2 more
-
London, United KingdomGSK Investigational Site
Jul 18, 2017
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Cambridge, Leeds, London (Overnight closed-loop, Real-time CGM
Completed
- Diabetes Mellitus
- +4 more
- Overnight closed-loop
- Real-time CGM alone
-
Cambridge, United Kingdom
- +2 more
Feb 28, 2017
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases Trial in Worldwide (Golimumab 50 mg SC, Golimumab 2 mg/kg IV, Methotrexate
Completed
- Arthritis
- +2 more
- Golimumab 50 mg SC
- +4 more
-
Birmingham, Alabama
- +116 more
Apr 9, 2015
Raynaud's Disease, Scleroderma, Autoimmune Diseases Trial in Sweden, United Kingdom, United States (Topical AmphiMatrix with
Completed
- Raynaud's Disease
- +2 more
- Topical AmphiMatrix with nitroglycerin (MQX-503)
-
Stanford, California
- +11 more
May 29, 2007
Immunologic Diseases, Autoimmune Diseases, Systemic Lupus Erythematosus Trial in Worldwide (Abetimus sodium (LJP 394))
Completed
- Immunologic Diseases
- +4 more
- Abetimus sodium (LJP 394)
-
Birmingham, Alabama
- +81 more
Sep 22, 2006